✦ LIBER ✦

A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu–Negative Metastatic Breast Cancer

✍ Scribed by Orlando Silva; Gilberto Lopes; Daniel Morgenzstern; Christopher Lobo; Philomena Doliny; Edgardo Santos; Sakher Abdullah; Umang Gautam; Isildinha Reis; Catherine Welsh; Joyce Slingerland; Judith Hurley; Stefan Gluck

Book ID: 119934794
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 116 KB
Volume: 8
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2008.n.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Weekly Docetaxel, Vino

Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

✍ Jeffrey R. Infante; Denise A. Yardley; Howard A. Burris III; F. Anthony Greco; C 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB

Phase II trial of a novel capecitabine d

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

P101 A multicenter phase II study of Epi

P101 A multicenter phase II study of Epirubicin with low-dose Herceptin as a first line treatment in HER-2 overexpressing metastatic breast cancer

✍ M. De Tursi; C. Carella; E. Ricevuto; A. Gennari; C. Orlandini; A. Frassoldati; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A multicenter phase II study of epirubic

A multicenter phase II study of epirubicin with low-dose trastuzumab as a first line treatment in Her-2 overexpressing metastatic breast cancer: preliminary results

✍ M. Zilli; De Tursi; C. Carella; E. Ricevuto; P. Marchetti; A. Gennari; C. Orland 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

A phase II randomized study comparing na

A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer

✍ M. Ghosn; P. Aftimos; F. S. Farhat; J. G. Kattan; C. Hanna; N. Haddad; F. Nasr; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 447 KB

Activity and safety of vinorelbine and c

Activity and safety of vinorelbine and capecitabine as first-line treatment in patients with metastatic breast cancer – a phase II trial

✍ R. Palumbo; A. Bernardo; M. Strada; C. Teragni; G. Poggi; M. Frascaroli; A. Amat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB